Introduction
============

Breast cancer is a leading cause of morbidity and mortality in women worldwide. In 2015, it reached 2.4 million cases in incidence while accounting for 15.1 million disability-adjusted life years.[@b1-ppa-12-1837] Mammography is currently the best screening tool for breast cancer and is linked to reduction in breast cancer mortality.[@b2-ppa-12-1837] However, with the current one-size-fits-all age-based screening, false positives and overdiagnosis are common.[@b3-ppa-12-1837] Hence, an optimized screening strategy based on individual woman's risk estimates has been advocated. It is suggested as being more efficient and effective than the age-based approach.[@b4-ppa-12-1837] Under this strategy, women at higher risk may undergo screening more frequently, while women at lower risk may be screened less frequently, allowing for earlier detection of breast cancer in the former and reducing harms associated with excessive screening in the latter.

Several risk stratification tools such as the Tyrer-Cuzick Model[@b5-ppa-12-1837] and the Breast Cancer Screening Consortium Risk Calculator[@b6-ppa-12-1837] are available. Researchers have recommended these tools to be incorporated in screening decisions.[@b7-ppa-12-1837] However, they are limited by moderate discriminatory accuracy.[@b8-ppa-12-1837],[@b9-ppa-12-1837] Recent genome-wide association studies have discovered multiple single-nucleotide polymorphisms (SNPs) in the population that are associated with breast cancer.[@b10-ppa-12-1837]--[@b15-ppa-12-1837] Although each SNP confers only low to moderate risk, they occur at higher frequencies than higher-penetrance BRCA mutations.[@b16-ppa-12-1837] When combined into a polygenic risk score (PRS), these SNPs improved the discriminatory accuracy of the existing risk assessment models[@b17-ppa-12-1837],[@b18-ppa-12-1837] and refined risk classification by shifting women at borderline low and high risk into low- and high-risk groups, respectively.[@b19-ppa-12-1837] Hence, risk stratification using PRS information may potentially inform risk-based screening strategies.[@b20-ppa-12-1837]

Furthermore, little is known about women perspectives regarding SNP gene testing for breast cancer risk.[@b21-ppa-12-1837]--[@b23-ppa-12-1837] Increasingly, regulators such as the United States Food and Drug Administration as well as the European Medicines Agency have been working on incorporating risk--benefit perspectives of patients in regulatory assessments.[@b24-ppa-12-1837],[@b25-ppa-12-1837] Likewise, in the health technology assessment process, the engagement of end-users broadens the perspective of recommendations given to decision makers[@b26-ppa-12-1837] and provides a real-world understanding of the benefits and risks of health technologies and possible future uptake.[@b27-ppa-12-1837]

Discrete choice experiments (DCEs) have been used to assess personal preferences, risk--benefit trade-offs and marginal rates of substitution (eg, marginal willingness-to-pay \[mWTP\]) in breast cancer screening.[@b28-ppa-12-1837]--[@b31-ppa-12-1837] This led to better understanding of women's trade-offs between benefits and costs of screening including intangible ones like false positives and overdiagnosis,[@b28-ppa-12-1837],[@b31-ppa-12-1837] importance of process attributes such as screening time and desire for privacy in influencing screening uptake[@b29-ppa-12-1837] and heterogeneity in preferences according to their socioeconomic background and health status.[@b31-ppa-12-1837] DCEs conducted in cancer gene testing[@b32-ppa-12-1837]--[@b35-ppa-12-1837] found that respondents value risk information and surveillance advice much more than assistance with decision making,[@b32-ppa-12-1837] prefer combinations of test characteristics that reflect future genomic testing more closely than current genetic testing[@b33-ppa-12-1837] and value cost and privacy more than reduction in false negatives.[@b35-ppa-12-1837] Yet, preferences for a one-time SNP gene testing to guide personalized screening strategies in breast cancer have not been extensively investigated. Hence, we aimed to estimate women's preferences and mWTP for the various aspects of SNP gene testing and to predict uptake in a multi-ethnic Singapore population using DCE.

Material and methods
====================

Recruitment and sample size
---------------------------

The study was conducted among women in the Singapore general population in December 2016. Multistage cluster sampling was employed (accompanying details in Supplementary materials). Screening-age women between 40 and 69 years were selected based on pre-specified ethnic quotas. Other eligibility criteria include Singapore citizenship and no prior history of breast cancer. Face-to-face surveys were conducted, and responses were recorded on tablet. All respondents provided written informed consent prior to participation. The study was approved by the National Healthcare Group Domain Specific Review Board (reference number: 2016/00184). Based on the Orme's Rule of Thumb,[@b36-ppa-12-1837] the minimum sample size required is 75. We aimed for 100 women in each of the three ethnicities, with a total of 300 women. This was planned before the publication of a practical guide on sample size requirements by de Bekker-Grob et al.[@b37-ppa-12-1837]

Ethics approval
---------------

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Study measures
--------------

Respondents were taken through a two-page explanation on SNP gene testing before completing the DCE. Sociodemographic characteristics, family history of breast cancer, and mammogram screening history were solicited. Respondents received S\$30 (ØS\$23) shopping vouchers as compensation for their time and effort.

DCE construction
----------------

As cost was included as one of the characteristics, mWTP can be calculated, to resemble real-world situations where money is spent to obtain improvement in certain characteristics of a good or service. Our DCE was developed based on good research practices.[@b38-ppa-12-1837] Details can be found in Supplementary materials. Input from screening-age women in a qualitative study,[@b39-ppa-12-1837] clinicians, health service researchers, and the literature informed the choice of attributes and their associated levels for the DCE ([Table 1](#t1-ppa-12-1837){ref-type="table"}). Notably, women in the study expected at least 90% test accuracy, defined as "how accurate the SNPs gene test is, in assessing risk of developing breast cancer," before they would consider doing the test. They were less concerned about overdiagnosis or false positives. Due to the lack of realistic estimates of risk stratification benefits, for example, proportion of late-stage cancers diagnosed and biopsy rate,[@b40-ppa-12-1837] we did not include them in the DCE.

Respondents were presented with a series of choice tasks and asked to choose one out of two alternatives labeled A and B in each task. They were then asked if they would really go for it in real life. This is known as a dual-response none question (closed-ended question in Part B of [Figure 1](#f1-ppa-12-1837){ref-type="fig"}, sample choice task). It prevents overestimation of screening uptake as preference for one option over another does not mean that the preferred option will be endorsed. Reasons for not going for the test were solicited in the open-ended question in Part B.

Sawtooth Lighthouse Studio 6.4.4. (Sawtooth Software, Orem, UT, USA) was used to generate 100 unique questionnaire versions, replicated in each of the three ethnicities, each containing one fixed task and 10 choice tasks randomly generated using balanced overlap method. It allowed for moderate attribute level overlap across alternative scenarios and better discrimination when respondents use non-compensatory rules in making decisions between choice alternatives.[@b41-ppa-12-1837] Although this reduced statistical efficiency as the number of levels that were directly compared was reduced, it lightened the cognitive burden on the respondents. A subset of the full-choice design (ie, fractional factorial design) was sampled for each respondent, while ensuring level balance and near-orthogonality within each respondent's profile.[@b42-ppa-12-1837] It was logically assumed that option A (buccal swab, specialist doctor, hospital, and S\$50) would be preferred to option B (dried blood spot, nurse educator, hospital, and S\$300) in the first (fixed) task, as revealed in the qualitative study. Hence, respondents who chose option B were excluded out of concerns that their data may be invalid.

Statistical analysis
--------------------

### Women's preferences

Respondent characteristics were described using counts and percentages for categorical variables and mean (SD) and median (interquartile range) for continuous variables. DCE data were estimated using mixed logit model in the preference space to calculate the part-worth utilities (PWUs) or preference weights for all attribute levels using Stata 14.2 (StataCorp LLC, College Station, TX, USA). Mixed logit was chosen over other models, for example, conditional logit, as it accounts for preference heterogeneity around parameter estimates among respondents, which was observed in our data as indicated by a likelihood ratio test for the joint significance of the standard deviations.[@b43-ppa-12-1837] A main effects model was estimated, with the attribute levels for "sample type," "person conducting pretest discussion," and "test location" being effects-coded and "out-of-pocket cost" being coded as a continuous variable, as our data showed a linear relationship with PWU when "out-of-pocket cost" was coded as categorical. Alternative-specific constants (ASC) for choosing the left-sided alternative and not to go for the test in real life (closed-ended question in Part B) were also included in the main effects model. Interactions between significant attribute levels and respondent characteristics were studied to determine the latter's effect on preferences for the attribute levels. The first category of each characteristic is the reference level ([Table 2](#t2-ppa-12-1837){ref-type="table"}). The final model was built using forward selection, where all attributes (main effects) were included, and only interaction terms between significant attributes and respondent characteristics (*P*\<0.05) were considered.

mWTP
----

Preferences among the ethnic groups were compared using marginal rates of substitution between out-of-pocket cost and other attributes, which is the same as mWTP. This resulted in normalization of coefficients by eliminating the scale coefficient and allowing direct comparison of preferences across the groups. mWTP of the overall study population was also studied, as it indicates the additional out-of-pocket cost that women are willing to pay in exchange for a more preferred level within an attribute. These were derived by estimating the mixed logit model in WTP space rather than preference space,[@b44-ppa-12-1837] with the cost coefficient being lognormally distributed and all other attribute coefficients being normally distributed. To assess mWTP heterogeneity, individual-level parameters were obtained post-estimation to construct probability density and cumulative density functions.[@b45-ppa-12-1837]

Predicted uptake
----------------

In budget impact analysis and program planning, one will be interested in predicted uptake. Details on the calculation of predicted uptake using PWU is in Supplementary materials. The mean indirect utility over all possible testing alternatives is fixed at zero. This means that the predicted uptake rates are estimated relative to the uptake rate of the grand mean. Alternatives include a realistic base case scenario reflecting current genetic testing (buccal swab, specialist doctor, hospital, and S\$175) and other options that are feasible, cheaper or pricier, and most preferred by the study population.

Dual-response none
------------------

Respondent choice in the closed-ended question of Part B (yes or no) was analyzed together with Part A, forming the DCE data. Proportion of women who chose not to undergo SNP gene test in real life at least once or all the time were described using counts and percentages. Responses to the open-ended question of Part B, that is, reasons for not going for the test were analyzed for commonality and coded accordingly, to derive categories of common responses.

Results
=======

Respondent characteristics
--------------------------

A total of 300 women completed the survey (300 out of 598 eligible dwelling units; 50.2% response rate). On average, the respondents took 22.6 minutes (SD: 10.5 minutes) to complete it. Reasons for non-participation included refusal and non-availability for re-appointment. The average age of respondents was 52.6 years (SD 7.6 years). Other respondent characteristics are presented in [Table 2](#t2-ppa-12-1837){ref-type="table"}.

Women's preferences and mWTP (n=300)
------------------------------------

Parameter estimates for the attribute levels are shown in [Table 3](#t3-ppa-12-1837){ref-type="table"}. All levels of sample type (*P*=0.046), person conducting pretest discussion, and out-of-pocket cost are statistically significant (*P*\<0.001), while all levels of test location are nonsignificant. Respondents preferred an SNP gene test that is less invasive (buccal swab), involving a pretest discussion with specialist doctor at a private family clinic. The least preferred combination is a more invasive test (dried blood spot) involving a non-specialist doctor at a public primary-care clinic. There is a positive association between choosing the left-sided alternative and opting for SNP gene testing (*P*\<0.001), reflecting a left-sided bias. However, a comparison between main effects models including and excluding the ASC "Choose left" found that the preference ranking within each attribute is similar except for the test location attribute ([Table S1](#SD1-ppa-12-1837){ref-type="supplementary-material"}), which is not significantly associated with going for SNP gene testing. In the model that included ASC "Choose left," private family clinic is most preferred, followed by hospital and public primary-care clinic. In the model that excluded ASC "Choose left," private family clinic is most preferred, followed by public primary-care clinic and hospital.

Interactions between respondent characteristics and attribute levels are also shown in [Table 3](#t3-ppa-12-1837){ref-type="table"}. Among four attributes and two ASCs, the interactions are significant only for out-of-pocket cost and ASC "Choose left." Those with household income \>S\$7,000 and high school senior education have overall lesser disutility toward out-of-pocket cost (*P*=0.005 and \<0.001, respectively), while blue-collar occupation attached greater disutility to cost (*P*=0.049). This implies that higher income women and those holding professional, managerial, or executive (PME, reference level) jobs are more willing to pay out-of-pocket than lower income women and blue-collar workers. Women with household income between S\$3,000 and S\$6,999 and women aged between 60 and 69 years attached lesser utility toward the left-sided alternative (*P*=0.015 and 0.002, respectively). Except for private family clinic, public primary-care clinic, and the interaction term between high school senior education and cost, we observed that the estimated SD coefficients for all other attribute levels are significant, indicating the presence of preference heterogeneity ([Table 3](#t3-ppa-12-1837){ref-type="table"}).

Probability density and cumulative density functions of individual mWTP are presented in [Figure 2](#f2-ppa-12-1837){ref-type="fig"}. Women are willing to pay to transit to buccal swab, specialist doctor, and to a lesser degree private family clinic, and not willing to pay for non-specialist doctor and public primary-care clinic, where the mWTP values are less than zero. Respondents are willing to pay the most for the transition from nurse educator to specialist doctor at S\$28.39 (95% CI S\$25.35, S\$31.42) and least willing to pay for the transition from nurse educator to non-specialist doctor at −S\$16.53 (95% CI −S\$19.18, −S\$13.88) ([Table 4](#t4-ppa-12-1837){ref-type="table"}).

Subgroup analyses
-----------------

Preferences among ethnic groups are represented by mWTP distributions in [Figure 3](#f3-ppa-12-1837){ref-type="fig"} and summarized in [Table 5](#t5-ppa-12-1837){ref-type="table"}. In general, they seem to be rather similar. With reference to the probability density functions, the Indians have narrower density distribution for buccal swab, concentrated around mWTP of S\$2.66. Together with the Malays, their densities are slightly shifted toward higher mWTP than the Chinese. For specialist doctor, the Malays have lower mWTP, depicted by the higher density than Chinese and Indians around mWTP of S\$15--S\$25. For non-specialist doctor, the Chinese appear to have a much longer right tail toward higher mWTP, although it is still in the negative range. They also appear to be more willing to pay for private family clinic, with higher density around mWTP of S\$13--S\$25. Cumulative density functions for all attributes seem to be comparable except for private family clinic, where the median mWTP of Chinese is S\$8.31 as compared to S\$6.99 in Malays and S\$7.63 in Indians ([Table 5](#t5-ppa-12-1837){ref-type="table"}). Chinese women have greater preference heterogeneity for the attributes as compared to the other two ethnicities, judging by the longer tails at both ends of the probability density functions.

Predicted uptake rates in various scenarios
-------------------------------------------

Predicted uptake rates for various scenarios are shown in [Table 6](#t6-ppa-12-1837){ref-type="table"}. A realistic base case scenario consisted of less invasive testing (buccal swab) involving a pretest discussion with a specialist doctor at the hospital which costs S\$175. Other scenarios include a feasible alternative that substitutes specialist doctor with nurse educator at a lower fee, cheaper alternative at S\$50, pricier alternative at S\$300, and the alternative consisting of the most preferred attribute levels at the population level (n=300). As compared to the base case, predicted uptake increase from 3.7% to 60.5% in feasible alternative and increase to 87.0% in cheaper alternative and 88.9% in most preferred alternative. Uptake decrease to almost 0% in pricier alternative, where cost is the highest at S\$300.

Dual-response none
------------------

One hundred of 300 women (33.3%) answered "No" to "Will you really go for this option in real life?" at least once in 10 choice tasks; 10 in 300 (3.3%) women always opted out of the SNP gene test in real life; 333 out of 3,000 choice tasks (11.0%) are answered as "No." Reasons include high cost (n=223), unaware of such tests (n=72), not keen to know the results (n=10), lack of time (n=10), afraid of taking blood (n=7), currently healthy therefore test is unnecessary (n=6), person conducting pretest discussion is not a specialist doctor (n=3), and others (n=2).

Discussion
==========

This is the first study to quantify women's preferences, mWTP, and predicted uptake for SNP gene testing in breast cancer. Our findings highlight the importance of incorporating culturally and linguistically appropriate services, as advocated by the National Committee of Quality Assurance which focuses on improving the quality of healthcare.[@b46-ppa-12-1837] We found that person conducting the pretest discussion and cost are significantly associated with women's choice of getting tested, while sample type (noninvasive buccal swab preferred) is only marginally significant (*P*=0.046). While preference for pretest discussion was not previously investigated, a recent DCE found that patients with chronic lymphocytic leukemia prefer to receive genomic test results from a hospital consultant doctor or specialist nurse rather than general practitioner or junior doctor.[@b33-ppa-12-1837] Similar to our findings, cost influences the attendance of cancer screening[@b31-ppa-12-1837] as well as pharmacogenetic test that predicts risk of life-threatening adverse drug reactions.[@b47-ppa-12-1837] Respondents also preferred noninvasive procedures in genome-based colorectal cancer screening scenarios.[@b48-ppa-12-1837]

Although we observed a bias toward the left-sided alternative, there is little difference between preference weights of attribute levels including and excluding the ASC "Choose left." Nonetheless, we considered the possibility that left-sided alternatives are consistently superior throughout the questionnaire. This is not found to be true when we checked through the design. Respondents could have been influenced by the first (fixed) task where option A was superior. Alternatively, they might have applied simplifying heuristics when undertaking this survey. However, we tried to minimize the application of heuristics by getting interviewers to emphasize to the respondents that either option may appeal more to them. We also did not observe any serial non-traders who always chose the left-sided option in every choice task.

Through the interactions analyses, we found that women with higher household income and education level were more willing to pay higher prices for SNP gene testing, while blue-collar workers were less willing than the self-employed or PME. This is in line with several studies demonstrating association between socioeconomic factors, for example, income and education on screening test uptake.[@b49-ppa-12-1837]--[@b51-ppa-12-1837] We observed significant preference heterogeneity for most attribute levels, suggesting the importance of tailoring SNP gene testing packages according to individual preferences, to maximize utility. Both the mean PWU and SD coefficients for buccal swab were significant at 5% level. By calculating the cumulative density function under the standardized normal curve, we find that 66% of the distribution is above zero, while 34% is below zero. This implies that buccal swab is associated with positive utility among about two-thirds of the respondents. The policy implication could be to provide buccal swab to those who self-select this option. Although preferences in terms of mWTP across ethnic groups appear to be comparable, there are subtle differences in mWTP for private family clinic and extent of preference heterogeneity. Nonetheless, cost-effectiveness of a one-size-fits-all strategy versus a personalized strategy should be empirically studied.

Women were willing to pay more to discuss with a specialist doctor, but not with a non-specialist doctor. However, this may not be the best use of specialist doctor' time. Since we found that nurse educator was preferred after specialist doctor, they can be considered as alternatives to specialist doctors. Research has shown that nurses trained in genetic counseling are well-positioned in providing such services[@b52-ppa-12-1837] and can be a cost-effective alternative to clinical geneticists.[@b53-ppa-12-1837] In many countries around the world including Singapore, experienced nurses are in shortage. Hence, institutions may consider training life science graduates or other allied health professionals as genetic counselors. We believe that women will be receptive toward genetic counselors if their proficiency and cost-effectiveness are demonstrated clearly.

As for predicted uptake, the feasible alternative in [Table 6](#t6-ppa-12-1837){ref-type="table"} appeared to be relatively well-received, achieving rates similar to that of a pharmacogenetic test to prevent severe adverse reactions[@b47-ppa-12-1837] and genome-based colorectal cancer screening.[@b48-ppa-12-1837] The cheaper and most preferred alternative may also become feasible in the future, as the cost of multi-panel gene testing becomes more affordable.[@b54-ppa-12-1837] The two most common reasons for opting out of the test in real life were high cost (n=233) and lack of awareness of such tests (n=72). This shows that the end-user's sensitivity toward price and knowledge of the health technology can influence its subsequent uptake. Nonetheless, only 3.3% of respondents always opted out, as compared to 21.4% who opted out of diabetes lifestyle management programs[@b55-ppa-12-1837] and 29.0% who opted out of medically supervised benzodiazepine discontinuation programs.[@b56-ppa-12-1837]

There are some limitations in this study. First, we assumed that both alternatives are equally highly accurate. Our study conclusions may change, depending on the clinical validity and utility of SNP gene testing. Second, the actual uptake of breast cancer screening in Singapore is rather low. Only about 40% of women aged 50--59 years and 38% of women aged 60--69 years surveyed in 2010 who participated in screening in the past 2 years.[@b57-ppa-12-1837] Similarly, only about 35% of our study sample attended mammogram screening within the past 2 years. Actual uptake of SNP gene testing may be even lower, as it only predicts the risk and not the actual occurrence of breast cancer. Nonetheless, SNP gene testing holds the promise of reducing screening harms for those at lower risk and detecting cancers earlier for those at higher risk. A large-scale prospective, randomized controlled trial is underway to determine whether screening based on personalized risk is as safe, less morbid, and more preferred by women than age-based screening.[@b20-ppa-12-1837] Other limitations include the uncertainty surrounding the use of heuristics or simplifying tactics to make decisions. Due to the nature of our sampling and recruitment, our study population tend to comprise housewives and women who were not working. They might have received lower education and have lower health literacy as compared to the general women population between 40 and 69 years. In addition, we could not reach out to women staying in condominiums or private apartments who earn higher incomes[@b58-ppa-12-1837] and may have higher health literacy. Last but not least, almost 50% of the eligible households did not participate in the study. These women may be less concerned with health-related issues and less willing to undergoing SNP gene testing in real life. Thus, our study findings may not be generalizable to them.

Conclusion
==========

Sample type, person conducting pretest discussion, and out-of-pocket cost are significantly associated with preference for SNP gene testing. Women with higher income and education levels were more willing to pay higher prices for the test. SNP gene testing using buccal swab involving a pretest discussion with a trained nurse educator at the hospital is more preferred and may be more cost-effective than the base case scenario involving specialist doctor at a higher cost. It could be personalized according to individual preferences to encourage uptake. Future research should focus on establishing the clinical validity and utility of SNP gene testing, the long-term outcomes of risk-based screening and prevention strategies, in terms of patients' experiences and survival as well as the cost-effectiveness of tailored breast cancer screening using SNP gene testing.

Data availability
=================

The data sets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Supplementary materials
=======================

Additional information on study methods
---------------------------------------

### Multi-stage cluster sampling

A market research company was commissioned to recruit respondents and implement the survey. Geographical clusters were first selected from the company's own residential sampling frame using systematic sampling. Due to access difficulties, condominium and private apartment dwellers (13.9% of the population) were excluded.[@b59-ppa-12-1837] Households in each Primary Sampling Unit were then selected door-to-door. Only one respondent per household could participate in the study.

### Discrete choice experiment (DCE) survey development

To fully capture women's views and beliefs toward single-nucleotide polymorphism gene testing to guide personalized screening strategies, focus group discussions involving screening-age Singaporean women were conducted. Data saturation was reached after four sessions. It was found that accuracy, invasiveness, cost, and side effects influence women's uptake of the test.

A pilot DCE survey was then conducted in 20 respondents, recruited in the same manner. Some respondents considered cousins as first-degree relatives in the question on family history of breast cancer. As such, we modified the question to read "has your biological mother, sister or daughter been diagnosed with breast cancer before?" Three out of 20 respondents did not understand the term "nurse educator." Hence, we included an explanation of the role of a nurse educator in the two-page write-up.

### Statistical analyses

Predicted uptake can be measured using the following formula:[@b60-ppa-12-1837],[@b61-ppa-12-1837] $$P\left( \text{accepting~alternative~i} \right) = \frac{1}{1 + e^{- \text{Vi}}}$$where Vi is the expected utility of alternative i, or the sum of part-worth utilities for the attributes corresponding to the specific levels. An alternative with expected utility V equals to zero is assumed to have a 50% probability of acceptance. Due to effects coding, all parameters are estimated relative to the grand mean, which has an expected utility of zero.

###### 

Comparison between PWUs of attribute levels of SNP gene testing including and excluding alternative-specific constant "Choose left" (main effects only)

  Attribute level                                                Mean PWU (95% CI)                                                     
  -------------------------------------------------------------- --------------------------------------------------------------------- ---------------------------------------------------------------------
  Buccal swab                                                    0.087 (−0.017, 0.190)                                                 0.070 (−0.014, 0.154)
  Dried blood spot[a](#tfn24-ppa-12-1837){ref-type="table-fn"}   −0.087 (−0.190, 0.017)                                                −0.070 (−0.154, 0.014)
  Specialist doctor                                              0.776 (0.617, 0.936)[d](#tfn25-ppa-12-1837){ref-type="table-fn"}      0.522 (0.398, 0.646)[d](#tfn25-ppa-12-1837){ref-type="table-fn"}
  Nurse educator[a](#tfn24-ppa-12-1837){ref-type="table-fn"}     −0.327 (−0.474, −0.180)[d](#tfn25-ppa-12-1837){ref-type="table-fn"}   −0.251 (−0.377, −0.125)[d](#tfn25-ppa-12-1837){ref-type="table-fn"}
  Non-specialist doctor                                          −0.449 (−0.602, −0.297)[d](#tfn25-ppa-12-1837){ref-type="table-fn"}   −0.271 (−0.387, −0.156)[d](#tfn25-ppa-12-1837){ref-type="table-fn"}
  Private family clinic                                          0.091 (−0.056, 0.238)                                                 0.084 (−0.037, 0.205)
  Hospital[a](#tfn24-ppa-12-1837){ref-type="table-fn"}           0.029 (−0.124, 0.183)                                                 −0.074 (−0.205, 0.057)
  Public primary-care clinic                                     −0.120 (−0.271, 0.031)                                                −0.010 (−0.133, 0.112)
  Out-of-pocket cost, per S\$100                                 −2.848 (−3.082, −2.613)[d](#tfn25-ppa-12-1837){ref-type="table-fn"}   −1.840 (−1.972, −1.709)[d](#tfn25-ppa-12-1837){ref-type="table-fn"}
  Alternative-specific constant(s)                                                                                                     
   Choose left                                                   2.092 (1.887, 2.296)[d](#tfn25-ppa-12-1837){ref-type="table-fn"}      NA
   Choose none                                                   −3.801 (−4.163, −3.439)[d](#tfn25-ppa-12-1837){ref-type="table-fn"}   −1.770 (−1.917, −1.623)[d](#tfn25-ppa-12-1837){ref-type="table-fn"}

**Notes:** Negative PWU represents disutility. Grand mean has an expected utility of zero.

Signifies the reference level of each attribute. Parameter estimates were obtained using the lincom command in Stata.

(*P*\<0.001).

**Abbreviations:** NA, not applicable; PWU, part-worth utility; SNP, single-nucleotide polymorphism.
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###### 

Probability density and cumulative density functions of mWTP in the overall study population.

**Abbreviation:** mWTP, marginal willingness-to-pay.

![](ppa-12-1837Fig2)

![](ppa-12-1837Fig2a)

###### 

Probability density and cumulative density functions of mWTP across three ethnic groups.

**Abbreviation:** mWTP, marginal willingness-to-pay.
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###### 

Attributes and levels of SNPs gene testing

  Attribute                                                         Levels
  ----------------------------------------------------------------- -------------------------
  1 Sample type                                                     1 Buccal swab
  2 Dried blood spot                                                
  2 Person conducting pretest discussion                            1 Specialist doctor
  2 Nurse educator trained in genetic counseling                    
  3 Non-specialist doctor                                           
  3 Test location                                                   1 Private family clinic
  2 Hospital                                                        
  3 Public primary-care clinic                                      
  4 Out-of-pocket cost[a](#tfn1-ppa-12-1837){ref-type="table-fn"}   1 S\$50 (US\$38)
  2 S\$175 (US\$134)                                                
  3 S\$300 (US\$229)                                                

**Note:**

US\$1 is approximately S\$1.31.

**Abbreviations:** SNP, single-nucleotide polymorphism; S\$, Singapore dollars.

###### 

Self-reported respondent characteristics (n=300)

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                                                              Total number\   Chinese\     Malay\       Indian\       *P*-value
                                                                                                              N (%)           N (%)        N (%)        N (%)         
  ----------------------------------------------------------------------------------------------------------- --------------- ------------ ------------ ------------- -----------
  **Sociodemographic characteristics**                                                                                                                                

  Total number of respondents                                                                                 300 (100.0)     100 (33.3)   100 (33.3)   100 (33.3)    

  Age in years (mean, SD)                                                                                     52.6 (7.6)      53.2 (8.0)   52.8 (7.2)   51.9 (7.5)    0.583

  Age in years (median, IQR)                                                                                  52 (13.0)       54 (14.0)    52 (11.0)    50.5 (11.3)   

  Marital status                                                                                                                                                      0.001

   Married with children                                                                                      246 (82.0)      72 (72.0)    86 (86.0)    88 (88.0)     

   Married without children                                                                                   14 (4.7)        8 (8.0)      2 (2.0)      4 (4.0)       

   Single                                                                                                     23 (7.7)        16 (16.0)    5 (5.0)      2 (2.0)       

   Divorced or separated                                                                                      11 (3.7)        4 (4.0)      3 (3.0)      4 (4.0)       

   Widowed                                                                                                    6 (2.0)         --           4 (4.0)      2 (2.0)       

  Highest education completed                                                                                                                                         \<0.001

   Elementary school and below                                                                                48 (16.0)       8 (8.0)      23 (23.0)    17 (17.0)     

   High school sophomore or technical school                                                                  178 (59.3)      47 (47.0)    66 (66.0)    65 (65.0)     

   High school senior                                                                                         46 (15.3)       29 (29.0)    10 (10.0)    7 (7.0)       

   College and above                                                                                          28 (9.3)        16 (16.0)    1 (1.0)      11 (11.0)     

  Housing type                                                                                                                                                        0.007

   Small public housing                                                                                       22 (7.3)        1 (1.0)      10 (10.0)    11 (11.0)     

   Medium public housing                                                                                      188 (62.7)      62 (62.0)    68 (68.0)    58 (58.0)     

   Large public housing                                                                                       82 (27.3)       33 (33.0)    19 (19.0)    30 (30.0)     

   Private apartment or landed property                                                                       8 (2.7)         4 (4.0)      3 (3.0)      1 (1.0)       

  Monthly household income                                                                                                                                            0.031

   Below S\$3,000                                                                                             88 (29.3)       25 (25.0)    36 (36.0)    27 (27.0)     

   S\$3,000--S\$6,999                                                                                         163 (54.3)      51 (51.0)    49 (49.0)    63 (63.0)     

   S\$7,000 and above                                                                                         49 (16.3)       24 (24.0)    15 (15.0)    10 (10.0)     

  Occupation                                                                                                                                                          \<0.001

   Self-employed/PME                                                                                          50 (16.7)       28 (28.0)    9 (9.0)      13 (13.0)     

   Other white-collar                                                                                         73 (24.3)       32 (32.0)    15 (15.0)    26 (26.0)     

   Blue-collar                                                                                                40 (13.3)       5 (5.0)      16 (16.0)    19 (19.0)     

   Housewife                                                                                                  121 (40.3)      28 (28.0)    53 (53.0)    40 (40.0)     

   Others, including retiree                                                                                  16 (5.3)        7 (7.0)      7 (7.0)      2 (2.0)       

  **Breast cancer related**                                                                                                                                           

   Had a first-degree relative (biological mother, sister, or daughter) diagnosed with breast cancer before   13 (4.3)        7 (7.0)      1 (1.0)      5 (5.0)       0.092

                                                                                                                                                                      

  Attended mammogram screening before                                                                         185 (61.7)      77 (77.0)    50 (50.0)    58 (58.0)     \<0.001

  Time since last mammogram screening                                                                                                                                 0.233

   \<1 year                                                                                                   47 (15.7)       22 (22.0)    9 (9.0)      16 (16.0)     

   1--2 years                                                                                                 57 (19.0)       24 (24.0)    13 (13.0)    20 (20.0)     

   2--3 years                                                                                                 29 (9.7)        8 (8.0)      9 (9.0)      12 (12.0)     

   3--5 years                                                                                                 13 (4.3)        4 (4.0)      6 (6.0)      3 (3.0)       

   \>5 years ago                                                                                              39 (13.0)       19 (19.0)    13 (13.0)    7 (7.0)       
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**Note:** One-way ANOVA was used to test for significant differences in age between groups while chi-squared test was used to test for significant differences in categorical variables between groups.

**Abbreviations:** IQR, interquartile range; PME, professional, managerial, or executive; S\$, Singapore dollars.

###### 

Respondent preferences (measured in PWUs) for attribute levels of SNP gene testing and interactions between respondent characteristics and attribute levels

  Attribute level[a](#tfn6-ppa-12-1837){ref-type="table-fn"}                                                     Mean PWU (95% CI)         *P*-value   SD of mean PWU (95% CI)[b](#tfn7-ppa-12-1837){ref-type="table-fn"}
  -------------------------------------------------------------------------------------------------------------- ------------------------- ----------- ---------------------------------------------------------------------
  Sample type                                                                                                                                          
   Buccal swab                                                                                                   0.122 (0.002, 0.242)      0.046       0.290 (0.099, 0.481)[e](#tfn10-ppa-12-1837){ref-type="table-fn"}
   Dried blood spot[c](#tfn8-ppa-12-1837){ref-type="table-fn"}                                                   −0.122 (−0.242, −0.002)   0.046       --
  Person conducting pretest discussion                                                                                                                 
   Specialist doctor                                                                                             1.032 (0.831, 1.233)      \<0.001     0.332 (0.099, 0.565)[e](#tfn10-ppa-12-1837){ref-type="table-fn"}
   Nurse educator[c](#tfn8-ppa-12-1837){ref-type="table-fn"}                                                     −0.443 (−0.620, −0.265)   \<0.001     --
   Non-specialist doctor                                                                                         −0.590 (−0.774, −0.406)   \<0.001     −0.336 (−0.553, −0.118)[e](#tfn10-ppa-12-1837){ref-type="table-fn"}
  Test location                                                                                                                                        
   Private family clinic                                                                                         0.158 (−0.019, 0.335)     0.080       0.273 (−0.019, 0.565)
   Hospital[c](#tfn8-ppa-12-1837){ref-type="table-fn"}                                                           −0.025 (−0.203, 0.152)    0.780       --
   Public primary-care clinic                                                                                    −0.133 (−0.304, 0.039)    0.130       −0.036 (−0.338, 0.266)
  Out-of-pocket cost, per S\$100                                                                                 −4.140 (−4.621, −3.660)   \<0.001     NA because coded as fixed
  Alternative-specific constants                                                                                                                       
   Choose left                                                                                                   2.843 (2.532, 3.153)      \<0.001     −0.318 (−0.545, −0.091)[e](#tfn10-ppa-12-1837){ref-type="table-fn"}
   Choose none                                                                                                   −5.437 (−6.113, −4.762)   \<0.001     2.645 (2.183, 3.106)[f](#tfn11-ppa-12-1837){ref-type="table-fn"}
  Significant interactions in the main effects + interactions model[a](#tfn6-ppa-12-1837){ref-type="table-fn"}                                         
   Age 60--69 × choose left                                                                                      −0.384 (−0.623, −0.145)   0.002       −0.303 (−0.596, −0.010)[d](#tfn9-ppa-12-1837){ref-type="table-fn"}
   Income S\$3,000--S\$6,999 × choose left                                                                       −0.251 (−0.453, −0.050)   0.015       0.573 (0.344, 0.803)[f](#tfn11-ppa-12-1837){ref-type="table-fn"}
   Income \>S\$7,000 × cost per S\$100                                                                           0.586 (0.178, 0.995)      0.005       1.382 (0.987, 1.777)[f](#tfn11-ppa-12-1837){ref-type="table-fn"}
   High school senior education × cost per S\$100                                                                0.917 (0.469, 1.366)      \<0.001     −0.181 (−0.799, 0.438)
   Blue-collar occupation × cost per S\$100                                                                      −0.694 (−1.384, −0.004)   0.049       0.846 (0.457, 1.236)[f](#tfn11-ppa-12-1837){ref-type="table-fn"}

**Notes:** Other variables in the model include (not significant): Indian ethnicity × cost per S\$100, age 50--59 × choose left, age 50--59 × cost per S\$100, age 60--69 × cost per S\$100, white-collar occupation × cost per S\$100, and other occupation × cost per S\$100. Reference levels for respondent characteristics are: age 40--49 years, household income \<S\$3,000, elementary school education, self-employed/professional, managerial, or executive, and Chinese ethnicity. Negative PWU represents disutility. Grand mean has an expected utility of zero.

All parameter estimates were derived from the mixed logit model with main effects plus interactions estimated in the preference space, as it was a better fit for the data as compared to main effects model (likelihood ratio test, *P*\<0.001).

The sign of the estimated standard deviations is irrelevant and should be interpreted as being positive. The likelihood ratio test for the joint significance of all standard deviations has a *P*-value of \<0.001, implying that the null hypothesis that all standard deviations are equal to zero is rejected, that is, there is significant preference heterogeneity.

Signifies the reference level of each attribute. Parameter estimates of reference levels were obtained using the lincom command in Stata.

*P*\<0.05.

*P*\<0.01.

*P*\<0.001.

**Abbreviations:** NA, not applicable; PWU, part-worth utility; SNP, single-nucleotide polymorphism; S\$, Singapore dollars.

###### 

Overall respondent mWTP for attribute levels of SNP gene testing (n=300)

  Attribute level                                                 Mean mWTP,[a](#tfn13-ppa-12-1837){ref-type="table-fn"} S\$ (95% CI)   *P*-value   SD of mean mWTP,[b](#tfn14-ppa-12-1837){ref-type="table-fn"} S\$ (95% CI)
  --------------------------------------------------------------- --------------------------------------------------------------------- ----------- ---------------------------------------------------------------------------
  Sample type                                                                                                                                       
   Buccal swab                                                    2.65 (0.79, 4.51)                                                     0.005       1.48 (−0.69, 3.65)
   Dried blood spot[c](#tfn15-ppa-12-1837){ref-type="table-fn"}   --                                                                    --          --
  Person conducting pre-test discussion                                                                                                             
   Specialist doctor                                              28.39 (25.35, 31.42)                                                  ,0.001      10.87 (7.93, 13.78)[e](#tfn17-ppa-12-1837){ref-type="table-fn"}
   Nurse educator[c](#tfn15-ppa-12-1837){ref-type="table-fn"}     --                                                                    --          --
   Non-specialist doctor                                          −16.53 (−19.18, −13.88)                                               ,0.001      −2.91 (−5.05, −0.77)[d](#tfn16-ppa-12-1837){ref-type="table-fn"}
  Test location                                                                                                                                     
   Private family clinic                                          7.70 (4.22, 11.17)                                                    ,0.001      15.39 (11.94, 18.84)[e](#tfn17-ppa-12-1837){ref-type="table-fn"}
   Hospital[c](#tfn15-ppa-12-1837){ref-type="table-fn"}           --                                                                    --          --
   Public primary-care clinic                                     −5.86 (−8.94, −2.79)                                                  ,0.001      −1.43 (−5.43, 2.57)

**Notes:**

mWTP figures were obtained from the same mixed logit model in [Table 3](#t3-ppa-12-1837){ref-type="table"} but estimated in WTP space (main effects plus interactions).

The sign of the estimated standard deviations is irrelevant and should be interpreted as being positive. The likelihood ratio test for the joint significance of all standard deviations has a *P*-value of \<0.001, implying that the null hypothesis that all standard deviations are equal to zero is rejected, that is, there is significant preference heterogeneity.

Signifies the reference level of each attribute.

(*P*\<0.01),

(*P*\<0.001).

**Abbreviations:** mWTP, marginal willingness-to-pay; SNP, single-nucleotide polymorphism; S\$, Singapore dollars.

###### 

Summary statistics of respondent mWTP estimates by ethnicity

  Attribute level                                           Statistic   mWTP[a](#tfn20-ppa-12-1837){ref-type="table-fn"} (S\$)                              
  --------------------------------------------------------- ----------- -------------------------------------------------------- -------- -------- -------- -------
  Buccal swab (reference level: dried blood spot)           Q1          2.32                                                     2.21     2.26     2.45     0.306
  Median                                                    2.61        2.54                                                     2.63     2.66              
  Q3                                                        2.88        2.81                                                     2.90     2.90              
  Mean                                                      2.58        2.51                                                     2.57     2.66              
  SD                                                        0.71        0.72                                                     0.75     0.66              
  Specialist doctor (reference level: nurse educator)       Q1          25.68                                                    25.93    24.76    25.64    0.930
  Median                                                    28.40       28.71                                                    28.17    27.99             
  Q3                                                        31.23       31.76                                                    31.30    30.63             
  Mean                                                      28.09       28.26                                                    28.09    27.91             
  SD                                                        6.47        7.50                                                     5.95     5.90              
  Non-specialist doctor (reference level: nurse educator)   Q1          −17.12                                                   −17.07   −17.20   −17.10   0.291
  Median                                                    −16.50      −16.60                                                   −16.47   −16.48            
  Q3                                                        −15.73      −15.61                                                   −15.86   −15.74            
  Mean                                                      −16.44      −16.31                                                   −16.62   −16.40            
  SD                                                        1.47        1.70                                                     1.29     1.39              
  Private family clinic (reference level: hospital)         Q1          3.29                                                     4.42     2.59     3.25     0.174
  Median                                                    7.73        8.31                                                     6.99     7.63              
  Q3                                                        11.95       12.92                                                    10.54    11.64             
  Mean                                                      7.71        8.91                                                     6.72     7.51              
  SD                                                        8.39        8.09                                                     8.13     8.86              
  Public primary-care clinic (reference level: hospital)    Q1          −6.16                                                    −6.27    −6.14    −6.10    0.915
  Median                                                    −5.82       −5.85                                                    −5.82    −5.78             
  Q3                                                        −5.52       −5.60                                                    −5.46    −5.50             
  Mean                                                      −5.85       −5.86                                                    −5.82    −5.85             
  SD                                                        0.66        0.80                                                     0.60     0.54              

**Notes:** One-way ANOVA was used to test for significant differences in mWTP estimates between ethnic groups.

mWTP figures were derived from the individual-level parameters obtained using the Stata post-estimation command *mixlbeta*. The results are slightly different from that in [Table 4](#t4-ppa-12-1837){ref-type="table"}.

**Abbreviations:** mWTP, marginal willingness-to-pay; Q1, first quartile; Q3, third quartile; S\$, Singapore dollars.

###### 

Predicted test uptake rates in various scenarios

  Attribute levels in each scenario      Realistic base case   Feasible alternative   Cheaper alternative   Pricier alternative   Most preferred alternative
  -------------------------------------- --------------------- ---------------------- --------------------- --------------------- ----------------------------
  Sample type                            Buccal swab           Buccal swab            Buccal swab           Buccal swab           Buccal swab
  Person conducting pretest discussion   Specialist doctor     Nurse educator         Specialist doctor     Specialist doctor     Specialist doctor
  Test location                          Hospital              Hospital               Hospital              Hospital              Private family clinic
  Cost                                   S\$175                S\$50                  S\$50                 S\$300                S\$50
  Test uptake rate (%)                                                                                                            
   All (n=300)                           3.7                   60.5                   87.0                  0.0                   88.9

**Abbreviation:** S\$, Singapore dollars.
